Zimbabwe has declined a major American health deal worth $367m (£272m) over five years because of Washington's request for confidential biological samples.
The decision became public after a government memo dated December was leaked, which showed Head of State Emmerson Mnangagwa deemed the agreement was "unbalanced".
An official representative has since clarified that the United States was requesting biological samples for scientific study and profit while was not willing to share the benefits from future medical innovations.
"We are forced to start the challenging and unfortunate task of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had donated more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for more dialogue to secure a agreement agreeable to all parties so the nation's vital HIV treatment initiative can be sustained.
Broader Context
This rejection follows a similar situation in Kenya, where a court halted a related deal with the US after concerns were raised about the security of citizens' medical information.
Since returning to the presidency recently, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
USAID had overseen assistance for the American government, but Trump claimed its spending was "wasteful" and his government was pursuing government-to-government deals to enhance transparency and responsibility.
Based on reports, 16 African countries have so far agreed to these new health pacts, representing over $18.3bn of fresh investment.
Specifics of the Declined Deal
This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership would have delivered significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently on antiretroviral therapy via US-supported initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, with no equivalent promise of benefiting from any medical innovations – like new medicines or tests – that could be developed from that provided information," he stated.
"In essence, our nation would provide the basic resources for scientific discovery with no certainty that the resulting innovations would be accessible to our population should a future health crisis emerge."
Sovereignty and International Frameworks
Mangwana further pointed out that the American exit from the global health body and its pursuit of one-on-one health agreements were undermining frameworks previously set up through the global organization.
The spokesperson cited its Pandemic Benefit-Sharing scheme designed to deal with future pandemics.
"This framework is designed to ensure that when a nation contributes its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to develop them."
The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," he added.
"We welcome continued discussions with our American counterparts on how subsequent collaboration might be arranged in a manner that honours the sovereignty and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but recommended that talks need to persist considering a large portion of the nation's HIV programmes were funded by international support.
"If specific concerns arise, such as those relating to data governance or implementation frameworks, these can frequently be resolved through technical clarification and mutually agreed protections," it commented.
The situation underscores the ongoing challenges between accepting crucial foreign assistance and safeguarding local interests in an ever more interconnected world.